A Crucial Role of Flagellin in the Induction of Airway Mucus Production by Pseudomonas aeruginosa by Mohamed, Fatima Ben et al.
A Crucial Role of Flagellin in the Induction of Airway
Mucus Production by Pseudomonas aeruginosa
Fatima Ben Mohamed
1,2*, Ignacio Garcia-Verdugo
1,2, Mathieu Medina
1,2, Viviane Balloy
1,2,
Michel Chignard
1,2, Reuben Ramphal
3, Lhousseine Touqui
1,2
1Unite ´ de De ´fense Inne ´e et Inflammation, Institut Pasteur, Paris, France, 2INSERM U.874, Paris, France, 3Department of Medicine, University of Florida, Gainesville,
Florida, United States of America
Abstract
Pseudomonas aeruginosa is an opportunistic pathogen involved in nosocomial infections. Flagellin is a P. aeruginosa
virulence factor involved in host response to this pathogen. We examined the role of flagellin in P. aeruginosa-induced
mucus secretion. Using a mouse model of pulmonary infection we showed that PAK, a wild type strain of P. aeruginosa,
induced airway mucus secretion and mucin muc5ac expression at higher levels than its flagellin-deficient mutant (DFliC).
PAK induced expression of MUC5AC and MUC2 in both human airway epithelial NCI-H292 cell line and in primary epithelial
cells. In contrast, DFliC infection had lower to no effect on MUC5AC and MUC2 expressions. A purified P. aeruginosa flagellin
induced MUC5AC expression in parallel to IL-8 secretion in NCI-H292 cells. Accordingly, DFliC mutant stimulated IL-8
secretion at significantly lower levels compared to PAK. Incubation of NCI-H292 cells with exogenous IL-8 induced MUC5AC
expression and pre-incubation of these cells with an anti-IL-8 antibody abrogated flagellin-mediated MUC5AC expression.
Silencing of TLR5 and Naip, siRNA inhibited both flagellin-induced MUC5AC expression and IL-8 secretion. Finally, inhibition
of ERK abolished the expression of both PAK- and flagellin-induced MUC5AC. We conclude that: (i) flagellin is crucial in P.
aeruginosa-induced mucus hyper-secretion through TLR5 and Naip pathways; (ii) this process is mediated by ERK and
amplified by IL-8. Our findings help understand the mechanisms involved in mucus secretion during pulmonary infectious
disease induced by P. aeruginosa, such as in cystic fibrosis.
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Introduction
The Gram-negative bacterium Pseudomonas aeruginosa is an
opportunistic human respiratory pathogen involved in a number
of nosocomial infections [1,2]. To protect its mucosal surfaces
from infections by pathogens, the host uses sophisticated
recognition systems including Toll-like receptors (TLRs) expressed
by mucosal epithelial cells and macrophages, which sense
conserved pathogen-associated molecular patterns (PAMPs)
[3,4,5]. P. aeruginosa expresses numerous PAMPs [6] among which
LPS and flagellin play a key role in host response to this bacterium,
through interactions with TLR4 and TLR5, respectively [7].
Flagellin is a protein that assembles as a hollow cylinder with a cap
to form the major portion of the bacterial flagellum [8]. Pre-
clinical evidences showed that defects in TLRs or in downstream
signalling pathways render the host susceptible to infection by
pathogenic bacteria including P. aeruginosa [9]. The nucleotide-
binding and oligomerization domain (NOD)-like receptor (NLR)
family have been also identified as intracellular pattern recognition
molecules for various microbial pathogens, including P. aeruginosa
[10]. Human NLR family is composed of numerous pattern
recognition molecules including NOD1, NOD2, Ipaf and Naip
reviewed in [10]. To date, it is known that NOD1 and NOD2
interact with bacterial cell wall components, whereas Ipaf and
Naip interact with bacterial flagellin [11]. Subsequent studies using
Salmonella and Legionella suggested redundancy between Ipaf and
Naip in the recognition of flagellin, but whether this finding can be
extrapolated to other bacteria remains to be determined [11]. It
has been shown that activation of NLRs leads to NF-kB or
Caspase-1 activation, resulting in subsequent secretion of pro-
inflammatory cytokines [11]. In contrast to Ipaf expression that is
restricted to macrophages, Naip is expressed in both macrophages
and lung epithelial cells [12].
Mucins are high-molecular weight and heavily glycosylated
proteins, produced by the mucosal cells to protect the mucosal
surface by trapping the inhaled infectious pathogens [13]. To date,
20 types of mucins have been identified [13,14,15], among them
MUC5AC and MUC5B are important components of airway
mucus in normal subjects [16]. MUC5AC and MUC5B are
involved in the pathogenesis of respiratory infectious diseases, such
as cystic fibrosis (CF) and chronic obstructive pulmonary disease,
and contribute considerably to amplification of inflammation and
tissue injury [13,14,15,17,18,19]. MUC2, that is expressed
normally by the intestinal epithelium, is highly elevated at the
mRNA level in CF airways and following exposition with P.
aeruginosa supernatant in vitro in NCI-H292 cells [20,21]. In
addition, increases in both MUC5AC and MUC2 mRNA levels
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39888have been reported in NCI-H292 cells after stimulation with P.
aeruginosa culture supernatant through MAP kinase pathway
[22,23]. Our previous study showed that P. aeruginosa-derived
LPS induced mucin expression [24], but the contribution of other
PAMPs and their receptors in this expression has not been fully
investigated. In addition, the mechanisms by which P. aeruginosa
infection leads to mucus secretion in airway epithelial cells remain
to be determined. The present work was undertaken to examine
the role of flagellin in P. aeruginosa-induced mucus secretion and to
determine the underlying mechanisms using human airway
epithelial cells and a mouse model of acute lung infection.
Results
Flagellin is Involved in Airway Mucus Secretion in P.
aeruginosa Infected Mice
Intranasal infection of mice with the wild type strain of P.
aeruginosa (PAK) for 24 hours induced a 3-fold increase in the
amount of pulmonary muc5ac mRNA in WT mice as compared to
PBS-treated mice (Fig. 1A). In contrast, under similar conditions,
infection of mice with the flagellin-deficient mutant (DFliC) did not
lead to a significant increase in muc5ac expression. A significant
difference in the level of muc2 mRNA was also detected between
PAK vs. DFliC lungs (Fig. 1B). However, no significant difference
in the level of muc5b mRNA was detected in the lung of mice
infected with PAK vs. DFliC (Fig. 1C). However, the number of
mucus-positive cells, as assessed by Alcian Blue staining, was
markedly decreased in the lung of mice infected with DFliC, as
compared to mice infected with PAK (Fig. 1D and E).
Interestingly, the decrease of mucins in the lung of mice infected
with DFliC was not associated with a decrease in the replication of
this mutant in the lung, because similar amount of bacteria was
detected in PAK and DFliC lungs, 24 h post-infection (Fig. 1F).
Similar amount of polymorphonuclear leucocyte (PMN) recruit-
ment was also detected in PAK and DFliC lungs, 24 h post-
infection (Fig. 1G). Interestingly, the decrease of mucins in the
lung of mice infected with DFliC was associated with a decrease in
the amount of KC produced in the lung following infection with
the DFliC mutant (Fig. 1H). Altogether, these findings suggest that
flagellin plays a critical role in stimulation of airway mucus
secretion in P. aeruginosa-infected mice.
P. aeruginosa Induces MUC5AC and MUC2 Expressions in
Human Airway Epithelial Cells through a Flagellin-
dependent Process
To investigate whether our finding can be extended to human
airway mucus secretion, we studied the effect of P. aeruginosa
infection on mucin expression by human airway epithelial cells,
NCI-H292. Infection of these cells with PAK led to an increased
MUC5AC expression both at mRNA (Fig. 2A) and protein levels
(Fig. 2B). This was accompanied by MUC5AC secretion into
culture medium (Fig. 2C). This induction was significant at PAK
MOI as low as 5 (Fig. 2A). Interestingly, both MUC5AC
expression and secretion were markedly reduced when cells were
infected with the DFliC mutant. In contrast, similar levels of LPS
were detected in the supernatants of NCI-H292 cells infected with
PAK or DFliC strains (Fig. 2D). Incubation of NCI-H292 cells
with the TLR4 inhibitor CLI-095 significantly reduced both PAK-
and DFliC-induced MUC5AC expression (Fig. 2E).
We next compared the effect of PAK and DFliC supernatants
on mucin expression in NCI-H292 cells. For this experiment, we
first ascertained that no flagellin was present in DFliC supernatant
(Fig. 3Aa) and that this mutant released similar levels of LPS
compared to PAK (Fig. 3E). Second, to determine the optimal
time of mucin expression, we performed a kinetic study of
mucin5AC expression in NCI-H292 cells stimulated with either
PAK or DFliC supernatant, using 3, 6, 10 and 24 time points.
Incubation of NCI-H292 cells with PAK supernatants led to an
increased MUC5AC expression at both mRNA and protein levels
(Fig. 3Ab, B and C). Our results indicate that the pic of expression
of MUC5AC occurred at 24-hrs in NCI-H292 cells stimulated
with PAK supernatant (Fig. 3Ab). Accordingly, all subsequent
experiments were carried out using the time point of 24-hrs. In
addition, the MUC5AC expression was significantly reduced in
cells stimulated with DFliC supernatants (Fig. 3Ab, B and C).
DFliC supernatants induced lower MUC5AC expression com-
pared to PAK supernatants, regardless of the dilutions used (1:64
to 1:4) (Fig. 3B). A complete inhibition of DFliC supernatant-
induced MUC5AC expression was achieved by incubating NCI-
H292 cells with the TLR4 inhibitor (Fig. 3D).
We also investigated whether flagellin is involved in the
induction of two other mucins, MUC2 and MUC5B. The results
showed that in comparison with living bacteria and supernatants
from PAK, DFliC mutant led to a significant reduction in MUC2
mRNA expression (Fig. 4A, B). A complete inhibition of DFliC-
induced MUC2 expression was achieved by incubating the cells
with the TLR-4 inhibitor (Fig. 4E). Neither PAK nor DFliC
mutant induced a significant level of MUC5B mRNA expression
by NCI-H292 cells (Fig. 4C, D). The level of LDH released into
the culture medium was less than 10% in both stimulated and
unstimulated control NCI-H292 cells, and this level was similar
regardless whether NCI-H292 cells were infected with PAK or
DFliC (Fig. S1-A and Fig. S2-A). This result indicates that PAK
and DFliC infections had no cytotoxic effect on of NCI-H292 cells.
Furthermore, no change in the levels of total protein was observed
following stimulation with PAK vs. DFliC (Fig. S1-B and Fig. S2-
B) suggesting that no cell detachment occurred following PAK and
DFliC infections. In addition, as indicated in Fig. 2E, there was no
difference in LPS production detected in supernatant of cells
stimulated with PAK vs. DFliC. Together, these findings suggest
that flagellin: (i) is involved in both MUC5AC and MUC2
expressions in NCI-H292 cells; and (ii) is released by bacteria at
sufficient amounts to induce these expressions.
P. aeruginosa Induces Mucin Expression in Human
Primary Bronchial Epithelial Cells
We next investigated whether our findings can be extended to
human primary bronchial epithelial cells. These cells were
differentiated in air-liquid interface and stimulated with superna-
tants from either PAK or DFliC. PAK supernatants induced
increased MUC5AC and MUC2 expressions in human primary
bronchial epithelial cells (Fig. 5A and B). Although these
expressions occurred at lower levels in human primary bronchial
epithelial cells as compared to the levels observed in NCI-H292
cells there was significantly reduction in cells stimulated with
DFliC vs. PAK supernatants. In agreement with the results
obtained with NCI-H292 cells, neither PAK nor DFliC superna-
tant were capable of inducing MUC5B mRNA expression
(Fig. 5C). In addition, the level of expression of the pro-
inflammatory cytokine IL-8 was significantly reduced in human
primary bronchial epithelial cells stimulated with DFliC superna-
tant compared to cells stimulated with PAK supernatant (Fig. 5D).
Purified P. aeruginosa Flagellin Induces MUC5AC
Expression through TLR5 and NAIP Receptors
The findings depicted above led us to examine the effect of
purified P. aeruginosa flagellin on mucins expression in epithelial
P. aeruginosa Flagellin Induces Mucus Secretion
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e39888Figure 1. Effect of flagellin on mucus secretion and lung inflammatory response induced by P. aeruginosa infection. C57BL/6 female
mice were infected for 24 hours with wild type P. aeruginosa strain (PAK) or its flagellin-deficient mutant (DFliC), (5610
6 CFU), as indicated in Material
and Methods. (A) Shows muc5ac expression in lungs of PAK-infected compared to DFliC-infected mice and (B) Shows muc2 expression in lungs of
PAK- and DFliC-infected mice. (C) Shows muc5b expression in lungs of PAK- and DFliC-infected mice. (D) Shows histological analysis with Alcian blue
staining of the lung. The photographs were taken using a 406magnification. The arrows point to mucus producing cells as stained by the blue
(Alcian blue-positive cells). (E) Shows the number of Alcian blue-positive cells that were calculated from 3 independent experiments (5 mice in each
group). (F) Shows bacteria amounts (CFU) in the lung detected 24 h following infection with 5610
6 CFU of either PAK- or DFliC. (G) Compares PMN
influx in the lung of PAK- and DFliC-infected mice. (H) Shows the amount of KC pro-inflammatory cytokine produced in the lung of mice (n=5), 24 h
post-infection with 5 610
6 CFU. nd = no detected, ns= not significant. ***P,0,001, **P,0.01 when comparing to PBS; &&& P,0.001, && P,0.01
when comparing DFliC to PAK infected lungs.
doi:10.1371/journal.pone.0039888.g001
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PLoS ONE | www.plosone.org 3 July 2012 | Volume 7 | Issue 7 | e39888Figure 2. Lack of flagellin compromises P. aeruginosa-induced MUC5AC expression in NCI-H292 cells. (A) Cells were exposed to various
MOI (5, 10 and 20 MOI) of the living PAK or DFliC strain for 24 h, then total mRNA was prepared and subjected to RT-qPCR using 18S as a standard.
The levels of MUC5AC protein present in cell lysates (B) and in supernatants (C) were measured using an ELISA assay, as described in Materials and
Methods. (D) Shows the levels of LPS in NCI-H292 supernatants after 1 h of infection with PAK or DFliC. (E) Shows the cells pre-treated with TLR4
inhibitor (TLR4i, 5 mM), as indicated in Material and Methods. before incubation with bacteria. The results are expressed as the percentage of
inhibition of MUC5AC mRNA expression in TLR4i treated vs untreated cells. Values represent means 6 SM of 3 independent experiments. *P,0.05,
**P,0.01 and ***P,0.001 when comparing PBS to infected cells. C = control. & P,0.05, && P,0.01, &&& P,0.001 when comparing DFliC to PAK
infected cells.
doi:10.1371/journal.pone.0039888.g002
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PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e39888Figure 3. Lack of flagellin reduces P. aeruginosa supernatant-induced MUC5AC expression by NCI-H292 cells. NCI-H292 cells were
exposed for 3, 6, 10 or 24 hrs to supernatants from either PAK or DFliC at 1:8 dilution (A, b) or at the indicated dilution (B). The Insert (A, a) indicates
immunoblotting analysis which shows the presence of flagellin in PAK (P) and its absence in DFliC (DF) supernatants. A 20 ng of purified flagellin
from PAK (Flag) was used as a positive control and the bacteria culture medium (LB) was used as a negative control. Total mRNA was extracted and
subjected to RT-qPCR (A, B). The level of MUC5AC protein produced in NCI-H292 supernatant was measured by ELISA, as indicated in Material and
Methods (C). In (D) NCI-H292 cells were pre-treated with TLR4i (5 mM) one hour before incubation with bacterial supernatants from either DFliC or PAK
and treated again during stimulation. The results show the percentage of inhibition of MUC5AC mRNA expression in TLR4i treated NCI-H292 cell
compared to untreated NCI-H292 cells. E) Shows the LPS levels in DFliC vs. PAK bacterial supernatant after 24 h of culture. C = control (untreated
cells), LB = Luria Bertoni medium 1:8 dilution. Values represent means 6 SM of 3 independent experiments. * P,0.05, ** P,0.01, *** P,0.001 vs
Control (C); &&& P,0.001, && P,0.01 vs. corresponding PAK-treated controls or LB.
doi:10.1371/journal.pone.0039888.g003
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PLoS ONE | www.plosone.org 5 July 2012 | Volume 7 | Issue 7 | e39888cells. Our results showed that purified flagellin was sufficient to
induce MUC5AC mRNA expression in epithelial cells (Fig. 6A).
This induction cannot be attributed to contamination by LPS,
because the latter was found at a low concentration in our
flagellin preparation(i.e. below 1 pg/ml). We showed that at
least 100 ng/ml of LPS was necessary to induce MUC5AC
Figure 4. Deletion of flagellin abrogates P. aeruginosa-induced MUC2 expression in NCI-H292 cells. Cells were exposed to various MOI of
living bacteria (A, C) or bacterial supernatants (B and D) as indicated in Material and Methods. Total mRNA was prepared and subjected to RT-qPCR to
measure MUC2 (A, B) and MUC5B (C, D) levels. (E) NCI-H292 cells were pre-treated with TLR4i (5 mM) one hour and then incubated with bacteria
supernatants. The result shows the percentage of inhibition of MUC2 mRNA expression following TLR4i treatment as compared to untreated control
cells. Values represent means 6 SM of 3 independent experiments. ns = no significant. C = control cells. * P,0.05 infected vs. no infected cells:
doi:10.1371/journal.pone.0039888.g004
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PLoS ONE | www.plosone.org 6 July 2012 | Volume 7 | Issue 7 | e39888expression in NCI-H292 cells (data not shown). We next
examined the role of flagellin receptors TLR5, Naip and Ipaf in
flagellin-induced MUC5AC expression. We showed that both
TLR5 and Naip, but not Ipaf, were expressed in NCI-H292
cells (Fig. 6B). Silencing of TLR5 and Naip reduced flagellin-
induced MUC5AC mRNA levels by 57% and 70%, respec-
tively, compared to siRNA controls (Fig. 6A). We verified that
TLR5 and Naip siRNA treatments reduced the levels of TLR5
and Naip by 70% and 50%, respectively (Fig. 6C and D).
These findings suggest that both TLR5 and Naip play a role in
flagellin-induced MUC5AC expression in NCI-H292 cells.
Flagellin Induces MUC5AC Expression Partially through
IL-8 Secretion by NCI-H292 Cells
Infection of NCI-H292 cells by PAK led to a time-dependent
increase of IL-8 secretion compared to DFliC (Fig. 7A). Similar
result was obtained when primary cells were stimulated with
bacterial supernatant (Fig. 5D). Our results also showed that
purified flagellin induced IL-8 secretion and that silencing of
TLR5 and Naip expressions significantly inhibited this secretion
(Fig. 7B). We next examined the possible role of IL-8 in
MUC5AC expression in flagellin-stimulated cells. Pre-incubation
of NCI-H292 cells with an IL-8 neutralizing antibody signif-
icantly decreased flagellin-induced MUC5AC expression (Fig. 7C)
compared with control antibody. In addition, stimulation of cells
with a recombinant IL-8 induced a three-fold increase in
MUC5AC mRNA levels (Fig. 7D). Finally, the expression of
MUC5AC in NCI-H292 cells stimulated by either PAK
supernatant or flagellin was abolished following MEK1/2
signalling pathway inhibition (Fig. 7E, F). However, treatment
of NCI-H292 cells with a P-38 signalling pathway inhibitor had
no effect on MUC5AC expression (data not shown). These
findings indicate that flagellin induced MUC5AC expression in
part through IL-8 secretion and that this process is mediated by
MEK1/2 signalling pathway.
Figure 5. Lack of flagellin reduces P. aeruginosa supernatant-induced mucin expression in human primary bronchial epithelial cells.
Human primary bronchial epithelial cells were exposed for 24 hours to supernatants from either PAK or DFliC at 1:8 dilution. Total mRNA was
prepared and subjected to RT-qPCR to measure MUC5AC (A), MUC2 (B) and MUC5B (C). (D) Shows the amount of IL-8 secreted into culture
supernatants of human primary bronchial epithelial following stimulation with either PAK or DFliC supernatant, as detected by ELISA. The Values
represent means 6 SM of 3 independent experiments from three different donors done in replicates. ns = no significant, *P,0.05, **P,0,01,
***P,0,001 stimulated vs. unstimulated control cells.
doi:10.1371/journal.pone.0039888.g005
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The present study demonstrated that flagellin plays a role in P.
aeruginosa-induced airway mucus secretion. Indeed, DFliC, the
flagellin-deficient mutant of P. aeruginosa induced mucin expression
and mucus secretion at much lower levels than the corresponding
wild type PAK strain, both in a mouse model of pulmonary
infection and in human bronchial epithelial cells, both primary
and cell line. Interestingly, our findings showed that bacterial
supernatants were able to induce mucin expression and that this
ability was markedly reduced in DFliC supernatants. This
suggested that flagellin is released in the incubation medium of
bacteria at sufficient amounts to induce mucin expression. This
was supported by the fact that P. aeruginosa flagellin stimulated
Figure 6. Impact of TLR5 and NAIP silencing on MUC5AC expression. NCI-H292 cells were transfected with TLR5 or Naip siRNA and then
treated with or without purified flagellin (Flag, 1 mg/ml) for 24 h. Scrambled siRNA was used as a negative control for transfection. (A) Shows the
effect of siRNA transfection on flagellin-induced MUC5AC expression. (B) Shows TLR5, Naip and Ipaf expression in NCI-H292 analyzed by RT-PCR. (C)
and (D) show the efficiency of siRNA transfection on TLR5 and Naip expressions compared to siRNA controls (C). Data are expressed as the means 6
SM. P,0,05. * P,0.05, ** P,0.01, *** P,0.001 vs Controls, 3 independent experiments.
doi:10.1371/journal.pone.0039888.g006
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PLoS ONE | www.plosone.org 8 July 2012 | Volume 7 | Issue 7 | e39888Figure 7. P. aeruginosa flagellin induces MUC5AC expression through IL-8 signalling. (A) NCI-H292 cells were exposed to PAK- or DFliC
bacteria supernatant for 3, 6, 10 or 24 hrs and the IL-8 secreted into culture supernatants was measured using an ELISA, as described in Materials and
Methods. (B) Shows IL-8 secretion by NCI-H292 cells after transfection by control siRNA (C), Naip siRNA or TLR5 siRNA with or without stimulation with
flagellin (at 1 mg/ml). (C) Shows MUC5AC expression by NCI-H292 cells after incubation with flagellin with anti-IL-8 neutralizing or isotype control
antibody. (D) Shows Induction of MUC5AC mRNA expression in NCI-H292 cells exposed to a rIL-8 (at 10 ng/ml). (E, F) shows the effect of ERK1/2
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PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e39888mucin expression by human airway epithelial cells. Interestingly,
the present studies also showed that flagellin is involved not only in
the induction of MUC5AC but also in MUC2 expression. Taken
together, these findings suggest that flagellin plays a role in the
induction of airway mucus secretion during P. aeruginosa lung
infection and that this process might have a pathophysiological
significance for lung diseases.
One may argued that the reduced ability of the DFliC mutant to
induce mucin expression might be due to the inability of this
mutant to effectively infect the mouse lung. This is unlikely
because our previous studies have clearly shown that flagellin
deletion did not reduce lung infection by this bacterium, but rather
increased it [25]. Indeed, in these studies DFliC exhibited slower
clearance from the lung compared to PAK strain in a mouse
model of acute lung infection [25]. This increase of infection with
flagellin-deficient bacteria was observed not only with P. pseudo-
monas but also with L. pneumophila [12]. In addition, in our in vitro
studies, reduced mucin expression by DFliC may not be due to
altered ability of this mutant to adhere to epithelial cells because
the latter were centrifuged after infection to achieve maximal
adherence of bacteria. Moreover, no flagellin was detected in
DFliC supernatant in which the levels of LPS were similar to those
found in PAK supernatant, indicating that the decreased mucin
expression induced by DFliC is clearly a consequence of lack of
flagellin in this strain.
It has been shown that P. aeruginosa induces MUC5AC secretion
by human airway epithelial cells through an LPS/TLR4
dependent mechanism [22,26]. To determine whether, in our
system, the LPS/TLR4 pathway is involved in mucin expression,
we used a pharmacological inhibitor of TLR4, CLI-095.
Unfortunately, LPS-deficient P. aeruginosa mutant was not available
because knocking LPS is lethal in P. aeruginosa. This pharmaco-
logical inhibition reduced significantly mucin expression induced
by both PAK and DFliC. This result also confirm our recent
finding indicating that P. aeruginosa LPS exacerbates mucus
secretion in a mouse model of CF [24]. Our results are also in
agreement with a recent study by Sun et al., showing that P.
aeruginosa induced-keratitis occurs through a TLR4/5 dependent
mechanism [27]. The present report also shows that the
pharmacological inhibition of TLR4 pathway during incubation
with PAK supernatants led to a partial inhibition of mucin
expression by epithelial cells. However, TLR4 inhibition com-
pletely abolished DFliC supernatant-induced-mucin expression.
These findings suggest that LPS and flagellin may act synergis-
tically or additively to induce mucin expression by epithelial cells.
They also suggest that LPS and flagellin were released by the
bacteria, at sufficient amounts, that stimulated mucin expression
by epithelial cells. However, one should kept in mind that other
PAMPs, such as pili and bacterial DNA may also play a role in the
induction of mucin in epithelial cell following P. aeruginosa
infection.
We next focused on the mechanisms by which flagellin induce
mucins expression in cultured human epithelial cells. In addition
to TLR5, flagellin is known to interact with Ipaf as well as with
Naip intracellular receptors [12]. Previous finding showed that
human Naip is expressed in both macrophages and lung epithelial
cells, in contrast to Ipaf expression that was restricted to the
macrophages [12]. Consistent with the above finding, our results
demonstrate that TLR5 and Naip, but not Ipaf, are expressed in
the human lung epithelial cells, NCI-H292. Given that Naip and
Ipaf have been previously suggested to exert redundant role in the
recognition of flagellin [28], Ipaf could compensate the absence of
Ipaf in our cell system. Using siRNA silencing strategy to
knockdown TLR5 and Naip, in lung epithelial cells, we showed
that purified flagellin induced MUC5AC expression through both
TLR5 and NAIP-dependent processes. A role of Naip-interaction
with flagellin was observed in the activation of inflammasome-
mediated innate immunity in mouse macrophages but not in
epithelial cells [29,30]. Interestingly, in lung epithelial cells, Naip
knockdown led to an enhanced replication of wild-type L.
Pneumophila, but not flagellin-deficient strain, suggesting the crucial
role of this receptor in the flagellin interaction and bacteria
replication [12]. In addition, in mice macrophages, Naip-5
specifically interacted with L. Pneumophila flagellin to induce
caspase-1 activation and IL-1b cytokine secretion [30]. In our
human lung epithelial cells model, neither the caspase-1 activation
nor the IL-1b secretion was detected after stimulation with P.
aeruginosa flagellin (Fig. S3). This suggests that the mucin expression
induced flagellin may be triggered through an IL-1b-independent
mechanism.
In a subsequent investigation we examined the possible
relationship between flagellin-induced mucin expression and pro-
inflammatory cytokine IL-8 secretion. Our results demonstrated
that IL-8 secretion was induced by P. aeruginosa partially via a
flagellin-dependent process. Indeed, stimulation of NCI-H292 cells
with DFliC mutant induced a significantly lower secretion of IL-8
compared to the PAK strain. Similar results were obtained
regardless of whether the cells were stimulated with the whole live
bacteria or with their supernatants. This result confirmed our
previous findings showing a lower level of keratinocyte-derived
cytokine (KC), the mouse orthologue of IL-8, in both broncho-
alveolar lavage and primary epithelial cells from mice infected
with the DFliC mutant [7,31]. Our data are also in agreement with
the pervious reports showing that incubation of human airway
epithelial cells with flagellin purified from P. aeruginosa induced IL-
8 secretion [32]. Similarly to MUC5AC, flagellin-induced IL-8
secretion was also reduced by siRNA silencing of TLR5 and Naip.
Interestingly, we showed that IL-8 mediates the effect of flagellin
on MUC5AC expression. This was based on our finding that a
neutralizing anti-IL-8 antibody reduced flagellin-induced MU-
C5AC expression in NCI-H292 cells. In addition, our results
indicated that recombinant IL-8 induced a significant increase in
MUC5AC expression, confirming a previous study showing that
IL-8 stimulates MUC5AC and MUC5B expression in NCI-H292
at the posttranscriptional level [33]. It has been also shown that
intratracheal instillation of murine recombinant chemoattractant
chemokines MCP-1, MCP-5 and KC induced mucin expression in
mouse lung [34]. However, these findings do not imply that these
chemokines are the only ones involved in mucin expression.
Other, yet to be determined, chemokines might also be involved in
this process.
In conclusion, we reported that P. aeruginosa flagellin plays a
critical role in the induction of airway mucus secretion both in
cultured human bronchial epithelial cells and in a mouse model
of lung infection by P. aeruginosa. This induction occurs via a
process involving TLR5 and Naip receptors, mediated by
MEK1/2 signalling pathway and amplified by IL-8. Our findings
would help design future therapeutic strategies to reduce airway
mucus secretion in chronic inflammatory lung disease such as
CF.
inhibitor PD98059 (20 mM) on MUC5AC expression by NCI-H292 cells stimulated with PAK supernatant or with purified flagellin. Values represent
means 6 SM of three independent experiments. * P,0.05, ** P,0.01, *** P,0.001 vs. LB.
doi:10.1371/journal.pone.0039888.g007
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Bacterial Strains and Growth Conditions
The P. aeruginosa wild type (WT) PAK strain, a widely studied
strain of P. aeruginosa and its aflagellated DFliC mutant in which the
FliC gene encoding flagellin was deleted [35] were prepared as
indicated previously [7]. For the bacterial supernatant, the WT
PAK and DFliC mutant were grown in LB medium for 24 h at
37uC. At equal quantity of bacteria, cell-free supernatants were
obtained by centrifugation at 4000 g for 15 min at 4uC and then
filtered through a 0.22 mm filter (Millipore, Molsheim, France). All
supernatants were aliquoted and stored at 280uC until used.
Mouse Infections
Females wild type (WT) C57BL/6 mice ,8 wk of age were
used the in vivo studies (Janvier Laboratories, France). Mice were
fed normal mouse chow and water ad libitum and were bred and
housed under standard conditions with air filtration. All animal
studies were approved by the Pasteur Institute Safety Committee
in accordance with French and European animal welfare
regulations and guidelines. Mice were anaesthetized by i.m.
adminstration of a mixture of ketamine (40 mg/Kg) and xylazine
(8 mg/Kg) and infected intranasally with bacterial doses equiva-
lent to approximately one-tenth of the LD50 of wild-type PAK
strain (i.e. 5610
6 colony-forming unit (CFU) per mouse), as
described previously [25].
Flagellin Preparation and LPS Quantification
Type A P. aeruginosa flagellin was prepared and purified as
described elsewhere [36]. To remove contaminating lipopolysac-
charide (LPS), the purified flagellin was passed through a
polymyxin B column, resulting in flagellin preparations with low
levels of LPS (,1 pg/mg flagellin). We also quantified the levels of
LPS in the supernatants of bacteria and NCI-H292 cells. Analysis
of LPS levels was performed using the Limulus amebocyte lysate
kit (Lonza, Basel, Switzerland). Flagellin protein purity was
determined by SDS-PAGE and Coomassie blue staining. Purified
proteins were quantified by the Bio-Rad protein assay (Bio-Rad,
Marnes-la-Coquette, France).
Alcian Blue/safranin Staining
Twenty-four hours post-infection, mice were euthanized
following an i.p. injection of an overdose of pentobarbital sodium
(300 mg/Kg). The chest was opened and lung perfused with sterile
PBS through the pulmonary artery to remove circulating blood. In
one series of experiments, the lung tissue was excised and
immediately fixed in Carnoy’s fixation (60% ethanol, 30%
chloroform and 10% glacial acetic acid). Tissue samples were
then embedded in paraffin and five-mm-thick sections were then
cut and mounted onto microscope slides for alcian blue/safranin
staining. Alcian blue (AB) powder (0.1 g) was dissolved in 100 mL
of acetic acid 3%. Concentrated HCl was added to lower the pH
value of the solution to 5. Sections were stained for 30 min
followed by washing with water. Sections were then stained using
1% safranin for 30 min, rinsed with ethanol, cleared in xylene and
mounted with Pertex mounting medium (Histolab Products Ab.,
Gothenburg, Sweden). The number of Alcian blue-stained cells
was measured. We performed analyses using MIRAX program
with help of histology department of Institut Pasteur. Images were
taken with a Nikon Eclipse E800 microscope (Nikon Corp.) and
were acquired using a Nikon Eclipse DXM1200 digital camera
(mounted on the Nikon Eclipse E800) and the Nikon ACT-1
software.
In Vitro Infection of Human Airway Epithelial Cell Cultures
with P. aeruginosa
Human epithelial NCI-H292 cells, obtained from American
Type Culture Collection (ATCC, Manassas, USA) were cultured
in RPMI-1640 medium supplemented with 200 mM L-glutamine,
10% (v/v) fetal calf serum, 100 UI/ml penicillin, 100 mg/ml
streptomycin, 2.5 mg/l glucose and buffered with 25 mM HEPES
at 37uC in a humidified, 5% CO2 water-jacketed incubator. For
stimulation purposes, NCI-H292 cells were seeded into 24-well
tissue-culture plates and grown until confluence. Cell stimulations
and infections were performed in free serum culture medium to
maintain a low basal level of mucins, as we [37] and others [38]
have recently described. Cells were suspended in the free serum
culture medium without antibiotics and stimulated with different
multiplicities of infection (MOI) of bacteria, as specified in the
figure legends. In order to increase the adherence between cells
and bacteria and to ensure similar contact between cells, PAK and
its non-motile DFliC mutant, infected cells were centrifuged (80 g,
4 min, 4uC). After one hour of incubation the bacteria were
removed and cells were washed three times in 40 mg/ml of
tobramycin medium (Sigma-Aldrich, Saint Quentin Fallavier,
France). Cells were then incubated with tobramycin medium for
30 min at 37uC and washed with the same medium three times to
ensure that all extracellular bacteria were removed or killed. Cells
were then incubated overnight in RPMI medium with 0.1% fetal
bovine serum and 1% antibiotic solution. In one series of
experiments, cell cultures were stimulated following an 18 hrs
exposure to several dilutions of bacteria supernatant as indicated
in figure legends in 0.1% serum-medium and compared with LB,
used as a control. In one series of experiments, cell cultures were
incubated with the TLR4 inhibitor, CLI-095 (Invivogen, San
Diego, USA) at a final concentration of 5 mM one hour before and
during stimulation with living bacteria or their supernatants.
In Vitro Stimulation of Human Airway Epithelial Cell with
Flagellin
In one series of experiments, cell cultures were stimulated with
1 mg/ml of flagellin for 24 hours. Cells were pre-incubated with an
anti-human CXCL8/IL-8 monoclonal antibody 5 mg/ml (R&D
System, Lille, France) one hour before and during the stimulation
with flagellin. In one series of experiments, the cells were
stimulated with human recombinant IL-8, 10 ng/ml (R&D
Systems, Lille, France),
Examination of Flagellin Secretion by Immunoblotting
Flagellin release was examined by immunoblotting of the
supernatants of bacteria grown at 37uC. At equal quantity of
bacteria, the cell-free supernatants from WT PAK and DFliC
mutant strains were diluted in RIPA buffer at 1/50. The purified
P. aeruginosa flagellin was used at 20 ng as a positive control. The
samples were then run on 15% native polyacrylamide gels and
transferred to nitrocellulose membranes for immunoblotting using
a non-commercial polyclonal rabbit antibody specific to P.
aeruginosa flagellin, that was recently described by Arora et al. [39].
Incubation of Differentiated Human Primary Bronchial
Epithelial Cells with P. aeruginosa Supernatant
Differentiated human primary bronchial epithelial cells, Muci-
lAir, were purchased from Epithelix (Epithelix Sarl, Geneve,
Switzerland). These cells were isolated from the bronchi of healthy
subject and cultured at air-liquid interface for 3 weeks in mucilAir
culture medium (Epithelix) until differentiation. To reduce basal
levels of mucin expression, cells were cultured for 48 h in BEBM
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The cells were then stimulated in the same medium with bacteria
supernatants or a equivalent dose of bacterial growth medium (LB)
and 24 h after RNA extractions were performed.
siRNA Transfection
ON-TARGET plus control siRNA, TLR5 and Naip siRNA
were purchased from Dharmacon (Abgen, UK). NCI-H292 cells
were incubated overnight in RPMI-1640 medium containing 10%
FBS so that cells were 60% confluent at the time of transfection.
Transfection was performed in OPTIMEM medium using
Lipofectamin 2000 (Invitrogen, Cergy Pontoise, France) as
transfection reagent and 100 nM final concentration of siRNA.
After 8 hours, transfection media was removed and new complete
media was added. Twenty-four hours after transfection, cells were
stimulated with 1 mg/ml of flagellin for an additional 24 hours.
Finally, cells were assayed for inhibition of targeted gene. In one
series of experiments, to neutralize IL-8, the anti-human CXCL8/
IL-8 antibody (R&D system, Lille, France) was incubated at 5 mg/
ml with cells 1 hour before and during the stimulation with
flagellin.
Real-time Polymerase Chain Reaction
Total RNA was extracted from cultured NCI-H292 cells or
from mice lung homogenate by RNeasy Mini Kit according to
manufacturers’ instructions (Qiagen, Courtaboeuf, France). One
mg of RNA was treated with recombinant RNAse-free DNAse I
(Roche, Meylan, France) and then, the corresponding cDNA was
synthesized using random hexamers (Roche, Meylan, France) and
M-MLV reverse transcriptase (Promega, Charbonnie `res-les-Bains,
France). Real-time polymerase chain reaction (RT-PCR) was
performed using an ABI 7900 RT-PCR detection system (Applied
Biosystems, Foster City, CA) in 10 ml reactions that contained 1 ml
of diluted cDNA, 300 nM each of forward and reverse primer,
and SYBR Green PCR Master Mix (Fisher scientific, Illkirch,
France). Each sample was run in duplicate for each gene and the
relative quantity (RQ) of mRNA was calculated based on the
housekeeping gene. Ct values were determined using Microsoft
Excel and the comparative Ct (DDCt) method, as described by the
manufacturer (Applied Biosystems). The amount of target
(2
2DDCT) was normalized to house keeping gene, using control
cells as calibrator (arbitrary units=1), unless stated otherwise. The
primers for MUC5AC, MUC2 and MUC5B have been previously
described [40]. The primer for human b-actine has been described
[37]. Other primers were designed using the Oligo Explorer 1.1. 2
software. The following is the sequence of these primers: human
TLR5 (Fw:59- TTCAACTTCCCAAATGAAGGA-39; Rv:59-
TTGCATCCAGATGCTTTTCA-39), human Naip (Fw:59-
CTTCACCCTGTGCCATTTCT-39; Rw:59-
AGAGCCGTGGTGAACTTTGT-39), human Ipaf (Fw:59-AC-
CCAAGCTGTCAGTCAGACC-39; Rw:59- CCAGTCCCCT-
CACCATAGAAG -39), mouse muc5ac (Fw:59- ACG-
GATGCTGCTATGACTG-39; Rv:59-
TGTGTGCTCTACCTTGTTGG-39), mouse muc2 (Fw:59-
CGACACCAGGGCTTTCGCTTAAT-39; Rv:59-CACTTC-
CACCCTCCCGGCAAAC-39), mouse muc5b (Fw:59-CATAGC-
CACTGCTCTTCT-39; Rv:59-CTGGCCTCTGTAACTATGT-
39), mouse Hypoxanthine–Guanine Phosphoribosyltransferase
(Hprt) (Fw:59- CAGGCCAGATTTGTTGGAT-39; Rv:59-
TTGCGCTCATCTTAGGCTTT-39).
ELISA Assay
MUC5AC ELISA was performed as previously described [41].
Briefly, 50 ml of cell lysate or 95 ml of culture supernatant were
diluted with carbonate/bicarbonate buffer (0.05 M final concen-
tration) and allowed to dry for at least 24 h in wells of a Maxisorb
(Nunc) 96-well plates at 40uC. Wells were washed 36with sterile
PBS and blocked with PBS/2% BSA (fraction V) before adding
100 ml of anti-MUC5AC mAb diluted to 1/600 (clone 45M1)
(Neomarkers Ab, Interchim, Montluc ¸on, France) in PBS/1%
BSA/0.1% Tween-20 for 1 h at room temperature. The plate was
then washed with PBS and further incubated with peroxidase-
conjugated goat anti-mouse IgG (1/10.000 in PBS/1% BSA/
0.1% Tween-20) (Sigma-Aldrich, Saint Quentin Fallavier, France)
for 1 h at room temperature. Peroxidase activity was detected
using 3,39,5,59-tetramethylbenzidine solution and stopped with 2N
H2SO4. Absorbance was read at 450nm OD. Because secretion of
MUC5AC protein by NCI-H292 cell changes with cell passages
[41] and that there is no commercial standard available for human
MUC5AC, its expression is represented as fold increase referred to
the basal secretion (control untreated NCI-H292 cells) tested
under same conditions. Total protein from cell lysates was
quantified by MicroBCA protein assay (Thermo scientific Pierce,
Illkirch, France) in order to eliminate effects of the stimuli on cell
proliferation.
Interleukin-8 (IL-8) secretion were measured in supernatants
using a human IL-8 Kit DuoSet sandwich ELISA (R&D Systems,
Lille, France), following manufacturers’ instructions.
Cytotoxicity Assay
Lactate dehydrogenase (LDH) activity was measured in the
supernatants of all culture using a cytotoxicity detection kit
(Roche), according to the manufacturer’s protocol. Results are
represented as percentage of LDH released into the supernatant
((supernatant/supernatant + lysate)6100= % LDH release). The
treatment is considered not cytotoxic with less than 10% of LDH.
Statistical Analysis
Data were represented as means 6 S.E. and compared using
the unpaired Student’s t test for the in vitro experiments and One-
Way ANOVA test for the in vivo experiments using Newman-Keuls
as secondary test to compare individual groups. P values less than
0.05 are considered significant.
Supporting Information
Figure S1 Infection of NCI-H292 cells with PAK and
DFliC bacteria results in no cytotoxic effect. (A) Shows
LDH level released in supernatants of NCI-H292 epithelial cells
(determined as % of total cell LDH) following infection with either
PAK or DFliC living bacteria. (B) Compares the level total proteins
detected in adherent NCI-H292 epithelial cells following stimu-
lation with either PAK or DFliC living bacteria. (C) Compares the
amount of bacteria (CFU) detected in NCI-H292 cell supernatants
after the first hour of infection with either PAK or DFliC mutant.
Results are representative of 3 independent experiments. ***
P,0.001 when comparing with T0. ns = not significant.
(TIFF)
Figure S2 Incubation of NCI-H292 cells with PAK and
DFliC supernatant did not trigger a cytotoxic effect. (A)
Shows LDH levels (% of total LDH) in supernatants of NCI-H292
epithelial cells incubated with either PAK or DFliC supernatant.
(B) Shows the levels of total proteins detected in adherent NCI-
H292 epithelial cells, following stimulation with either PAK or
DFliC supernatant. Results are representative of 3 independent
experiments. * P,0.05 when comparing PAK to DFliC. ns = not
significant.
(TIFF)
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H292 cells. Cells were left unstimulated (NS) or stimulated with
purified flagellin (Flag) at 1 mg/ml for 24 hours. Sixty mg of whole
cell lysates were used for immunoblotting. Whole cell lysates from
MH-S cells, macrophages cell line (Mac), stimulated with PAK at
1 MOI was used as a positive control (C). An anti-IL-1b
polyclonal goat antibody from Santa Cruz was used at 1/200
overnight at 4uC. The second anti-goat polyclonal antibody was
used at 1/20000 for one hour at room temperature. b-actine was
used as a control for protein loading. The first anti-b-actine
polyclonal antibody was purchased from Sigma and used at 1/
20000 for one hour at room temperature. The anti-mouse second
antibody was used at 1/20000 for one hour. Results are
representative of 3 independent experiments. ns = not significant.
(TIFF)
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